Killing Cancer Stem Cells With Chemicals

In late 2009, a multi-institutional team of researchersemerging idea in cancer biology that tumors can
from the Broad Institute at MIT and Harvardharbor a group of cells within them that have a
discovered an exciting new chemical that specificallyunique ability to regenerate cancers, which in addition
targets aggressive cells within breast cancers thatto promoting the growth of tumors are also
normally have the ability to seed new tumors; theseextremely resistant to current cancer therapies. By
cells are otherwise known as cancer stem cells. Theidentifying chemicals which can specifically kill these
general concept is that most medical practitioners andcancer stem cells, these chemicals may be used in
scientists believe that these specific cancer stem cellsfuture drug development to create cancer-seeking
allow cancer to spread throughout the body, possiblydrugs that literally seek and destroy the cancerous
reemerging after treatments that otherwise seemcells within the body.
successful. Currently, the research has only beenUnfortunately, these cancer stem cells are extremely
performed on mice, but the study does show thatrare, and considering that they lose their properties
there is a possibility for chemicals that can be used inwhen grown outside of the body, research has been
the human body to selectively kill cancer cells at theirseverely limited due to a lack of material available for
primary core: the stem cell.analysis; however, there are a variety of studies
Studying Stem Cellsunderway seeking to establish a better consensus.
According to Robert Weinberg, one of the authorsA Future Cancer Cure?
of the study and a member of the WhiteheadResearchers from Broad and Whitehead Institute
Institute for Biomedical Research, "Evidence ishave used additional research to generate a fairly
accumulating rapidly that cancer stem cells arelarge number of these cancer cells in laboratory
responsible for the aggressive powers of manyenvironments. Unfortunately, this has only been
tumors. The ability to generate such cells in thecompleted on mice and limited in scope to focusing
laboratory, together with the powerful techniquesupon breast cancer in particular. The compound they
available at the Broad Institute, made it possible todiscovered is called salinomycin. It destroys not only
identify this chemical. There will surely be dozens ofcancer stem cells created in the laboratory, but also
others with similar properties found over the nextthose which are naturally occurring. Salinomycin, when
several years."compared to the common chemotherapeutic drug
The paper was published in the medical journal Cell,paclitaxel, reduced the number of cancer stem cells
and the lead author, Eric Lander - director of theby more than 100-fold in 30 mice. In addition, it also
Broad Institute of MIT and Harvard and professor ofreduced the size of the breast tumors that it did not
systems biology at Harvard Medical School - sayseliminate completely.
that, "Many therapies kill the bulk of the tumor onlyWhile not conclusive by any means, the evidence is
to see it grow. This raises the prospect of new kindsfairly compelling and has sparked further research into
of anti-cancer therapies."the cure for cancer.
The evidence was fairly overwhelming and backs an